checkAd

     411  0 Kommentare BioConnect and EyeVerify Collaborate to Improve Identity and Authentication in Financial Sector

    TORONTO, ON--(Marketwired - August 30, 2016) - BioConnect and EyeVerify are delighted to announce a licensing agreement that includes the integration of Eyeprint ID into the BioConnect platform. As the world of finance continues to be one of the fastest consumers of biometric technology, the need for security and a frictionless user experience for authentication is becoming more and more apparent. As biometrics are something you are, cannot be shared, borrowed or forgotten, they have surfaced as a clear front-running solution to help reduce fraud, manage KYC measures and reduce operational inefficiencies.

    BioConnect is proud to partner with one of the leaders in mobile biometric technologies: EyeVerify. Eyeprint ID, from EyeVerify, uses existing 1+ MP smartphone cameras to image and pattern match the unique pattern of eye veins and other micro features in and around the eye. It is the only biometric that protects user data with a high entropy encryption key -- equivalent to a 50-character complex password.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Wells Fargo & Company!
    Short
    64,32€
    Basispreis
    0,55
    Ask
    × 8,84
    Hebel
    Long
    52,99€
    Basispreis
    0,57
    Ask
    × 8,66
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    "EyeVerify is one of the highest standards of mobile-friendly security and built perfectly for the Financial Services industry: secure and frictionless," said Bianca Lopes, VP Strategic Marketing and Global Alliances at BioConnect. "We are proud to partner, and can't wait for the possibilities that come with this as we, together, fundamentally change how we verify our identity in financial applications and combat fraud."

    BioConnect began the build out of its ubiquitous BioConnect Identity Platform 7 years ago, primarily focusing on security and physical access control. Its efforts developing strong relationships and integrations with leaders in physical access control resulted in the accumulation of an infrastructure of over 20 strong integrations "to the door." The subsequent build out of a hardware and device agnostic platform will enable biometric authentication in the physical and digital world. This enables large enterprises to consume all biometrics as an authentication strategy without changing existing legacy infrastructure.

    Chris Barnett, EVP Global Sales and Marketing at EyeVerify, states, "We fully believe in BioConnect's Quest for Rightful Identity, and are pleased to be included in their mobile platform. We think Eyeprint ID is a perfect fit for BioConnect customers seeking convenient, private and secure authentication."

    This partnership with BioConnect and EyeVerify will enable the technology leader to accelerate its growth by being part of the BioConnect Platform. With integration, strong partnership and custom work, the partnership of these two companies will see the transformation of how enterprises can consume biometric technology.

    Both companies will be in attendance at Finovate in New York on September 8-9 celebrating innovation in FinTech.

    Image Available: http://www.marketwire.com/library/MwGo/2016/8/29/11G112071/Images/EyeVerify_BioConnect-5015229161fabc31bfb4cffb771119be.jpg

    PR Contacts:

    Jessica Gagner
    BioConnect
    647-971-8418
    jgagner@bioconnect.com

    Tinna Hung
    EyeVerify
    tinna.hung@eyeverify.com





    Verfasst von Marketwired
    BioConnect and EyeVerify Collaborate to Improve Identity and Authentication in Financial Sector TORONTO, ON--(Marketwired - August 30, 2016) - BioConnect and EyeVerify are delighted to announce a licensing agreement that includes the integration of Eyeprint ID into the BioConnect platform. As the world of finance continues to be one of the …

    Schreibe Deinen Kommentar

    Disclaimer